IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LAWRENCE KELLY

NPI
1629031901
CMS profile
118291
Location
CHARLESTON, WV

General Payments · PY2018–2024

$47,657.42

  • Reported across 583 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,104.44

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: WV All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,009.44 53
Education $95.00 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $516.53 25
ABBVIE INC. $152.50 10
Axsome Therapeutics, Inc. $113.23 2
Takeda Pharmaceuticals U.S.A., Inc. $74.52 5
Vanda Pharmaceuticals Inc. $62.18 3
Otsuka America Pharmaceutical, Inc. $57.83 3
Lundbeck LLC $54.25 3
Alkermes, Inc. $29.40 1
Corium, Inc. $28.05 1
ITI, Inc. $15.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $7,972.36 116
PY2019 $19,107.28 89
PY2020 $13,189.16 84
PY2021 $3,609.97 102
PY2022 $1,214.80 68
PY2023 $1,459.41 70
PY2024 $1,104.44 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $15.24 01/09/2024 Food and Beverage Undisputed 01/23/2026 1104050386 CMS
ABBVIE INC. $15.94 02/01/2024 Food and Beverage Undisputed 01/23/2026 1104050388 CMS
ABBVIE INC. $12.62 03/14/2024 Food and Beverage Undisputed 01/23/2026 1104050390 CMS
ABBVIE INC. $17.89 03/28/2024 Food and Beverage Undisputed 01/23/2026 1104050392 CMS
ABBVIE INC. $10.29 04/22/2024 Food and Beverage Undisputed 01/23/2026 1104050394 CMS
ABBVIE INC. $16.37 06/03/2024 Food and Beverage Undisputed 01/23/2026 1104050396 CMS
ABBVIE INC. $20.18 07/29/2024 Food and Beverage Undisputed 01/23/2026 1104050398 CMS
ABBVIE INC. $23.09 09/16/2024 Food and Beverage Undisputed 01/23/2026 1104050400 CMS
ABBVIE INC. $14.53 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104050402 CMS
ABBVIE INC. $6.35 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104050404 CMS
Alkermes, Inc. $29.40 04/23/2024 Food and Beverage Undisputed 01/23/2026 1120529259 CMS
Axsome Therapeutics, Inc. $99.95 01/09/2024 Food and Beverage Undisputed 01/23/2026 1148298420 CMS
Axsome Therapeutics, Inc. $13.28 01/25/2024 Food and Beverage Undisputed 01/23/2026 1148298418 CMS
Corium, LLC $28.05 10/08/2024 Food and Beverage Undisputed 01/23/2026 1100211205 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.95 04/30/2024 Food and Beverage Undisputed 01/23/2026 1143255485 CMS
Lundbeck LLC $17.42 04/08/2024 Food and Beverage Undisputed 01/23/2026 1145932511 CMS
Lundbeck LLC $21.38 06/17/2024 Food and Beverage Undisputed 01/23/2026 1145932513 CMS
Lundbeck LLC $15.45 11/18/2024 Food and Beverage Undisputed 01/23/2026 1145932515 CMS
Otsuka America Pharmaceutical, Inc. $15.62 07/25/2024 Food and Beverage Undisputed 01/23/2026 1118920262 CMS
Otsuka America Pharmaceutical, Inc. $16.05 08/22/2024 Food and Beverage Undisputed 01/23/2026 1118920264 CMS
Otsuka America Pharmaceutical, Inc. $26.16 09/09/2024 Food and Beverage Undisputed 01/23/2026 1118920266 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.13 06/11/2024 Food and Beverage Undisputed 01/23/2026 1137598393 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.30 07/10/2024 Food and Beverage Undisputed 01/23/2026 1137598397 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.96 09/12/2024 Food and Beverage Undisputed 01/23/2026 1137598400 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.29 10/09/2024 Food and Beverage Undisputed 01/23/2026 1137598404 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.84 11/21/2024 Food and Beverage Undisputed 01/23/2026 1137598408 CMS
Teva Pharmaceuticals USA, Inc. $23.27 01/06/2024 Food and Beverage Undisputed 01/23/2026 1151527703 CMS
Teva Pharmaceuticals USA, Inc. $21.46 01/26/2024 Food and Beverage Undisputed 01/23/2026 1151527705 CMS
Teva Pharmaceuticals USA, Inc. $21.42 02/10/2024 Food and Beverage Undisputed 01/23/2026 1151527721 CMS
Teva Pharmaceuticals USA, Inc. $2.41 02/23/2024 Food and Beverage Undisputed 01/23/2026 1151527723 CMS
Teva Pharmaceuticals USA, Inc. $11.55 02/23/2024 Food and Beverage Undisputed 01/23/2026 1151527725 CMS
Teva Pharmaceuticals USA, Inc. $20.56 03/09/2024 Food and Beverage Undisputed 01/23/2026 1151527737 CMS
Teva Pharmaceuticals USA, Inc. $23.27 04/06/2024 Food and Beverage Undisputed 01/23/2026 1151527749 CMS
Teva Pharmaceuticals USA, Inc. $95.00 04/16/2024 Education Undisputed 01/23/2026 1151527835 CMS
Teva Pharmaceuticals USA, Inc. $12.03 04/18/2024 Food and Beverage Undisputed 01/23/2026 1151527751 CMS
Teva Pharmaceuticals USA, Inc. $21.42 04/27/2024 Food and Beverage Undisputed 01/23/2026 1151527753 CMS
Teva Pharmaceuticals USA, Inc. $23.33 05/17/2024 Food and Beverage Undisputed 01/23/2026 1151527769 CMS
Teva Pharmaceuticals USA, Inc. $14.70 05/31/2024 Food and Beverage Undisputed 01/23/2026 1151527793 CMS
Teva Pharmaceuticals USA, Inc. $14.70 06/07/2024 Food and Beverage Undisputed 01/23/2026 1151527795 CMS
Teva Pharmaceuticals USA, Inc. $15.18 06/21/2024 Food and Beverage Undisputed 01/23/2026 1151527797 CMS
Teva Pharmaceuticals USA, Inc. $18.36 07/12/2024 Food and Beverage Undisputed 01/23/2026 1151527811 CMS
Teva Pharmaceuticals USA, Inc. $18.36 07/26/2024 Food and Beverage Undisputed 01/23/2026 1151527813 CMS
Teva Pharmaceuticals USA, Inc. $19.44 08/09/2024 Food and Beverage Undisputed 01/23/2026 1151527823 CMS
Teva Pharmaceuticals USA, Inc. $17.91 08/23/2024 Food and Beverage Undisputed 01/23/2026 1151527825 CMS
Teva Pharmaceuticals USA, Inc. $18.90 08/30/2024 Food and Beverage Undisputed 01/23/2026 1151527841 CMS
Teva Pharmaceuticals USA, Inc. $18.36 09/13/2024 Food and Beverage Undisputed 01/23/2026 1151527843 CMS
Teva Pharmaceuticals USA, Inc. $18.68 10/04/2024 Food and Beverage Undisputed 01/23/2026 1151527853 CMS
Teva Pharmaceuticals USA, Inc. $22.12 10/18/2024 Food and Beverage Undisputed 01/23/2026 1151527855 CMS
Teva Pharmaceuticals USA, Inc. $18.68 11/01/2024 Food and Beverage Undisputed 01/23/2026 1151527867 CMS
Teva Pharmaceuticals USA, Inc. $3.57 11/15/2024 Food and Beverage Undisputed 01/23/2026 1151527869 CMS
Teva Pharmaceuticals USA, Inc. $21.85 11/16/2024 Food and Beverage Undisputed 01/23/2026 1151527871 CMS
Vanda Pharmaceuticals Inc. $19.80 09/19/2024 Food and Beverage Undisputed 01/23/2026 1133908555 CMS
Vanda Pharmaceuticals Inc. $14.53 10/24/2024 Food and Beverage Undisputed 01/23/2026 1133908557 CMS
Vanda Pharmaceuticals Inc. $27.85 12/04/2024 Food and Beverage Undisputed 01/23/2026 1133908559 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.